AGM outcomes include MD re-appointment, new statutory auditor and director pay hikes

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹98.25

prior close

₹97.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+0.4% vs market

Pharmaceuticals peers, median of 173sector-0.8%-0.1% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.1

15m

-0.1

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9-1.3+0.4-0.8-0.1

Next day

+0.8-1.3+2.0-1.3+2.0

-1.3+0.0-1.3-0.4-0.9

-0.1-0.2+0.1-0.1+0.0

-4.3-3.0-1.3-3.0-1.2

-3.6-2.7-0.8-3.1-0.5

-5.3-1.7-3.6-3.0-2.3

15d

+35.4-8.9+44.2-7.1+42.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Asston Pharmaceuticals held its 7th AGM on Sept 29, 2026. Members approved: (1) FY26 audited standalone financials; (2) re-appointment of Mr. Ashish Sakalkar as Managing Director; (3) appointment of M/s Panchal S K and Associates as Statutory Auditors; (4) higher remuneration for MD, Whole-time Director and CEO Mrs. Saili More, and Non-Executive Director Mr. Sachin Badakh.

Likely market impact

Routine AGM business confirming continuity in leadership and audit. Director pay hikes will lift costs slightly but signal board alignment.